Sepetaprost

A prostaglandin analog used in glaucoma treatment

Sepetaprost
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Sepetaprost is a prostaglandin analog that has been investigated for its potential use in the treatment of glaucoma and ocular hypertension. It is a synthetic compound designed to mimic the effects of naturally occurring prostaglandins, which are lipid compounds that perform a variety of hormone-like actions in the body.

Mechanism of Action

Sepetaprost functions primarily by increasing the outflow of aqueous humor from the eye, thereby reducing intraocular pressure (IOP). This is achieved through its action on the prostaglandin F receptor, which is involved in the regulation of aqueous humor dynamics. By binding to these receptors, sepetaprost facilitates the drainage of fluid through the uveoscleral pathway, a secondary route for aqueous humor outflow.

Pharmacokinetics

The pharmacokinetic profile of sepetaprost involves its absorption, distribution, metabolism, and excretion. Upon administration, sepetaprost is absorbed into the ocular tissues where it exerts its therapeutic effects. It is metabolized primarily in the liver and excreted through the kidneys. The half-life of sepetaprost in the human body is relatively short, necessitating regular dosing to maintain its therapeutic effects.

Clinical Use

Sepetaprost has been studied in clinical trials for its efficacy in lowering intraocular pressure in patients with glaucoma and ocular hypertension. These conditions are characterized by elevated IOP, which can lead to optic nerve damage and vision loss if left untreated. By reducing IOP, sepetaprost helps to prevent the progression of these diseases.

Side Effects

Common side effects associated with sepetaprost include ocular irritation, conjunctival hyperemia (redness of the eye), and changes in eyelash growth. These side effects are similar to those observed with other prostaglandin analogs used in the treatment of glaucoma.

Development and Research

Research into sepetaprost has focused on its potential advantages over existing prostaglandin analogs, such as improved efficacy or reduced side effects. Ongoing studies aim to further elucidate its safety profile and long-term effects in patients with glaucoma.

Related Pages

• Glaucoma
• Prostaglandin
• Ocular hypertension
• Intraocular pressure